You may benefit from a personalized medical weight loss program if you're experiencing: Persistent hunger or frequent food cravings Difficulty losing weight despite diet and exercise Weight regain after previous diets or weight loss programs Increased abdominal or visceral fat Fatigue or low energy Insulin resistance, prediabetes, or type 2 diabetes High blood pressure or elevated cholesterol Hormonal weight gain related to perimenopause or menopause Slow metabolism or difficulty maintaining muscle A desire for a medically supervised approach to long-term weight management These challenges can affect far more than the number on the scale
You can look into Novo Nordisks Patient Assistance Program (PAP), Wegovy Saving card, Ozempic Saving Card, Rybelsus saving card, Medicare, Medicaid, and private insurance coverage, according to your eligibility
The durable compounding is in everything built around it.
Where the molecule is FDA-approved Across this drug class, FDA-approved indications include type 2 diabetes for most compounds, chronic weight management for products such as Wegovy, Saxenda, and Zepbound, cardiovascular risk reduction in type 2 diabetes for several products, and, as of 2024, obstructive sleep apnea in adults with obesity for Zepbound